Neuroleptic treatment and negative symptoms in deficit and nondeficit schizophrenia.
Bustillo
J R
JR
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore 21228, USA.
Kirkpatrick
B
B
Buchanan
R W
RW
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011596:Psychomotor Disorders / Q000209:etiology*; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy*; D012720:Severity of Illness Index
D014150:Antipsychotic Agents; D002746:Chlorpromazine